Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models

KN Zabegalov, TO Kolesnikova, SL Khatsko… - European Journal of …, 2018 - Elsevier
Antidepressant drugs are currently one of the most prescribed medications. In addition to
treatment resistance and side effects of antidepressants, their clinical use is further …
被引用次数：12 相关文章

Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models

KN Zabegalov, TO Kolesnikova… - European journal …, 2018 - pubmed.ncbi.nlm.nih.gov
Antidepressant drugs are currently one of the most prescribed medications. In addition to
treatment resistance and side effects of antidepressants, their clinical use is further …

[引用][C] Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models

KN Zabegalov, TO Kolesnikova, SL Khatsko… - European Journal of …, 2018 - elibrary.ru
The research was supported by the Russian Foundation for Basic Research (RFBR) grant
16-04-00851 to АVK. RRG was supported by a Russian Science Foundation (RSF) grant 14 …

Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models.

KN Zabegalov, TO Kolesnikova, SL Khatsko… - European Journal of …, 2018 - europepmc.org
Antidepressant drugs are currently one of the most prescribed medications. In addition to
treatment resistance and side effects of antidepressants, their clinical use is further …

[引用][C] Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models

KN Zabegalov, TO Kolesnikova, SL Khatsko… - European Journal of …, 2018 - cir.nii.ac.jp
Understanding antidepressant discontinuation syndrome (ADS) through preclinical
experimental models | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …